MindWalk/$HYFT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About MindWalk
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Ticker
$HYFT
Sector
Primary listing
Employees
92
Headquarters
Website
MindWalk Metrics
BasicAdvanced
$58M
-
-$0.51
0.48
-
Price and volume
Market cap
$58M
Beta
0.48
52-week high
$2.99
52-week low
$1.15
Average daily volume
464K
Financial strength
Current ratio
4.188
Quick ratio
3.988
Long term debt to equity
18.108
Total debt to equity
20.486
Interest coverage (TTM)
-60.72%
Profitability
EBITDA (TTM)
-6.71
Gross margin (TTM)
57.62%
Net profit margin (TTM)
-111.94%
Operating margin (TTM)
-38.96%
Effective tax rate (TTM)
8.32%
Revenue per employee (TTM)
$212,120
Management effectiveness
Return on assets (TTM)
-15.08%
Return on equity (TTM)
-118.22%
Valuation
Price to revenue (TTM)
2.734
Price to book
3.26
Price to tangible book (TTM)
3.26
Price to free cash flow (TTM)
-7.108
Free cash flow yield (TTM)
-14.07%
Free cash flow per share (TTM)
-0.176
Growth
Revenue change (TTM)
49.46%
Earnings per share change (TTM)
-29.82%
3-year revenue growth (CAGR)
10.18%
3-year earnings per share growth (CAGR)
-14.58%
MindWalk News
AllArticlesVideos
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
Business Wire·4 weeks ago
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
Business Wire·1 month ago
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MindWalk stock?
MindWalk (HYFT) has a market cap of $58M as of February 26, 2026.
What is the P/E ratio for MindWalk stock?
The price to earnings (P/E) ratio for MindWalk (HYFT) stock is 0 as of February 26, 2026.
Does MindWalk stock pay dividends?
No, MindWalk (HYFT) stock does not pay dividends to its shareholders as of February 26, 2026.
When is the next MindWalk dividend payment date?
MindWalk (HYFT) stock does not pay dividends to its shareholders.
What is the beta indicator for MindWalk?
MindWalk (HYFT) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.